Gregory Reyes
CIK 1404055 · Senior VP, Research · last filed 2026-07-21
Gregory Reyes is a Senior VP, Research who has filed 12 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for ARTL, was dated Jul 21, 2026. Across all open-market trades the lifetime net is +$8.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
12
$8.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARTL | Director | — | $0.75 | — | $0 | 3 | 2026-07-21 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Director | — | $0.01 | — | $0 | 6 | 2024-03-01 |
| Bio Green Med Solution, Inc. (CYCCP) Delisted | Senior VP, Research | 3,000 | $5.05 | $15.2K | $8.7K | 3 | 2008-03-21 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-21 | ARTL | Grant (A) | — | $0 | EDGAR |
| 2026-02-02 | ARTL | Grant (A) | — | $0 | EDGAR |
| 2024-12-23 | ARTL | Grant (A) | — | $0 | EDGAR |
| 2024-03-01 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Mixed | — | $0 | EDGAR |
| 2023-08-08 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-03 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-26 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-07 | ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-03-21 | Bio Green Med Solution, Inc. (CYCCP) Delisted | Mixed | +3,000 | $8.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.